Retractable Technologies (NYSE:RVP) Now Covered by StockNews.com

Research analysts at StockNews.com assumed coverage on shares of Retractable Technologies (NYSE:RVP) in a note issued to investors on Thursday. The brokerage set a “hold” rating on the stock.

Retractable Technologies Stock Performance

Shares of RVP opened at $0.82 on Thursday. The company has a 50-day moving average of $0.69 and a two-hundred day moving average of $0.81. The stock has a market cap of $24.42 million, a price-to-earnings ratio of -1.51 and a beta of 1.94. The company has a debt-to-equity ratio of 0.01, a current ratio of 8.57 and a quick ratio of 5.92. Retractable Technologies has a one year low of $0.56 and a one year high of $1.34.

Institutional Inflows and Outflows

A hedge fund recently bought a new stake in Retractable Technologies stock. PFG Investments LLC purchased a new stake in shares of Retractable Technologies, Inc. (NYSE:RVP) during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 34,600 shares of the company’s stock, valued at approximately $27,000. PFG Investments LLC owned 0.12% of Retractable Technologies as of its most recent SEC filing. 7.58% of the stock is owned by institutional investors.

About Retractable Technologies

Retractable Technologies, Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.